Pulmonary emphysema induced by methylphenidate
experimental study
Keywords:
Methylphenidate, Attention deficit disorder with hyperactivity, Pulmonary emphysema, Rats, LungAbstract
CONTEXT AND OBJECTIVE: Methylphenidate is the most widely used drug for treating attention deficit hyperactivity disorder. However, it has important side effects, such as abdominal pain, insomnia, anorexia and loss of appetite, and also some cases of early severe emphysema after drug abuse have been reported. Our aim was to investigate the development of pulmonary emphysema in rats that were subjected to dif-ferent doses of methylphenidate. DESIGN AND SETTING: Experimental study carried out at the laboratory of a public university. METHODS: Eighteen male Wistar rats were divided into three groups: control (0.9% saline solution); MP 0.8 (methylphenidate, 0.8 mg/kg); MP 1.2 (methylphenidate, 1.2 mg/kg). After 90 days of daily gavage, the ani-mals were sacrificed and lung tissue samples were prepared for analysis on the mean alveolar diameter (Lm). RESULTS: The Lm was greater in MP 0.8 (47.91 ± 3.13; P < 0.01) and MP 1.2 (46.36 ± 4.39; P < 0.05) than in the control group (40.00 ± 3.48). CONCLUSION: Methylphenidate caused an increase in the alveolar diameter of rats, which was compatible with human pulmonary emphysema.
Downloads
References
Kay J, Tasman A. Psiquiatria – ciência comportamental e fundamentos clínicos. São Paulo: Manole; 2000.
Ball C. Attention-deficit hyperactivity disorder and the use of methylphenidate. The Psychiatric Bulletin. 2001;25(8):301-4. Available from: http://pb.rcpsych.org/content/25/8/301.full.pdf+html. Accessed in 2014 (Aug 1).
Burguess IC. Service innovations: attention-deficit hyperactivity disorder – development of a multi-professional integrated care pathway. The Psychiatric Bulletin. 2002;26(4):148-51. Available from: http:// pb.rcpsych.org/content/26/4/148.full.pdf+html. Accessed in 2014 (Aug 1).
Ishimatsu M, Kidani Y, Tsuda A, Akasu T. Effects of methylphenidate on the membrane potential and current in neurons of the rat locus coeruleus. J Neurophysiol. 2002;87(3):1206-12.
Faraone SV, Biederman J, Mick E. The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies. Psychol Med. 2006;36(2):159-65.
Janicak PG, Davis JM, Preskorn SH, Junior FJA. Princípios e práticas empsicofarmacoterapia. Rio de Janeiro: Medsi; 1996.
Efron D, Jarman F, Barker M. Side effects of methylphenidate and dexamphetamine in children with attention deficit hyperactivity disorder: a double-blind, crossover trial. Pediatrics. 1997;100(4):662-6.
Golinko BE. Side effects of dextroamphetamine and methylphenidate in hyperactive children--a brief review. Prog Neuropsychopharmacol Biol Psychiatry. 1984;8(1):1-8.
Pastura G, Mattos P. Efeitos colaterais do metilfenidato [Side effects of methylphenidate]. Rev Psiquiatr Clín (São Paulo). 2004;31(2):100-4.
Sherman CB, Hudson LD, Pierson DJ. Severe precocious emphysema in intravenous methylphenidate (Ritalin) abusers. Chest. 1987;92(6):1085-7.
Thai DL, Yurasits LN, Rudolph GR, Perel JM. Comparative pharmacokinetics and tissue distribution of the d-enantiomers of para-substituted methylphenidate analogs. Drug Metab Dispos. 1999;27(6):645-50.
Barkley RA, McMurray MB, Edelbrock CS, Robbins K. Side effects of methylphenidate in children with attention deficit hyperactivity disorder: a systemic, placebo-controlled evaluation. Pediatrics. 1990;86(2):184-92.
Spencer T, Biederman J, Wilens T, et al. Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle. J Am Acad Child Adolesc Psychiatry. 1996;35(4):409-32.
Kuraki T, Ishibashi M, Takayama M, Shiraishi M, Yoshida M. A novel oral neutrophil elastase inhibitor (ONO-6818) inhibits human neutrophil elastase-induced emphysema in rats. Am J Respir Crit Care Med. 2002;166(4):496-500.
Ritalina (Cloridato de Metilfenidato): comprimidos [bula de remédios]. Responsável técnico: Marcos A. J. Brazil: Novartis; 2011. Available from: http://www.anvisa.gov.br/datavisa/fila_bula/frmVisualizarBula.asp?pNuTransacao=10716102013&pIdAnexo=1909485. Accessed in 2014 (Aug 19).
Spencer T, Bierdeman J, Wilens TE, Faraone SV. Adults with attention-deficit/hyperactivity disorder: a controversial diagnosis. J Clin Psychiatry. 1998;59 Suppl 7:59-68.
Shekim WO, Asarnow RF, Hess E, Zaucha K, Wheeller N. A clinical and demographic profile of a sample of adults with attention deficit hyperactivity disorder, residual state. Compr Psychiatry. 1990;31(5):416-25.